Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $3.0 million.

  • Cross Country Healthcare's Gains from Investment Securities changed 0.0% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 7246.73%. This contributed to the annual value of $3.0 million for FY2024, which is 3964.11% down from last year.
  • Cross Country Healthcare's Gains from Investment Securities amounted to $3.0 million in FY2024, which was down 3964.11% from $4.9 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Gains from Investment Securities peaked at $5.3 million during FY2022, and registered a low of -$990000.0 during FY2020.
  • Moreover, its 5-year median value for Gains from Investment Securities was $3.0 million (2024), whereas its average is $2.9 million.
  • As far as peak fluctuations go, Cross Country Healthcare's Gains from Investment Securities tumbled by 22359.55% in 2020, and later surged by 32525.25% in 2021.
  • Annual analysis of 5 years shows Cross Country Healthcare's Gains from Investment Securities stood at -$990000.0 in 2020, then soared by 325.25% to $2.2 million in 2021, then soared by 136.19% to $5.3 million in 2022, then decreased by 6.89% to $4.9 million in 2023, then plummeted by 39.64% to $3.0 million in 2024.
  • Its Gains from Investment Securities was $3.0 million in FY2024, compared to $4.9 million in FY2023 and $5.3 million in FY2022.